Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Scroll Up
Scroll Down

Analysis of a New High Throughput Screening Detection Technology for Rapid hERG Safety Testing using a Fluorescence Polarization Assay
Bookmark and Share

Biotek Instruments

Background
Speed and sensitivity are the hallmarks of Fluorescence Polarization (FP) assay technologies. Due to this FP has seen penetration in the drug discovery and drug development markets for High Throughput Screening applications. For a good overview of applications/target audiences for FP here is an easy to read and interesting White Paper with good citations for further reading: Fluorescence Polarization in Life Sciences. The Predictor hERG biochemical FP assay has been used as a model of FP performance validation used on our Synergy lines, not only because it is an assay designed for HTS run at low volume in 384-well plates, but because quantification of hERG channel binding and inhibition are cardio toxicity tests recommended for all drug compounds before human use (e.g. in pre-clinical trials). Therefore, the assay needs to prove it can compare with GLP-compliant gold standard methods, and the detection technology used to produce that data must be rigorous enough to do the same. Although BioTek has published a number of pieces of marketing collateral using the Predictor hERG assay, until Synergy Neo, other Synergy models could only provide sensitivity acceptable for detection of this assay at the cost of speed. Publication of optimal read parameters was either largely ignored or minimized in the other BioTek collateral for this reason, as the combination of assay and detection parameters required for optimal data were largely prohibitory for HTS applications when competitors could do it at ~ 2 min plate read time within a 2 hour assay incubation window.

Further Information

Related Content

BioTek Introduces New General Manager in Germany
Company appoints Dr. Frank Siefert who will be responsible for managing day-to-day operations in Germany.
Tuesday, November 03, 2015
BioTek to Exhibit at Neuroscience 2015
Join BioTek Instruments as they demonstrate the latest microplate innovations at the SfN’s 45th annual meeting. Neuroscience 2015 will be held October 17-21 at McCormick Place in Chicago, IL. BioTek will showcase their products at booth #1809.
Tuesday, September 29, 2015
BioTek Readers Receive BellBrook Certifications
Company’s multi-mode microplate readers earn Transcreener HTS Assay certifications.
Friday, September 11, 2015
BioTek Readers Receive Promega DLReady™ Certification
Promega’s Dual-Luciferase© Reporter System demonstrate both companies’ common commitment.
Friday, August 07, 2015
BioTek Expands in the United Kingdom
Company expands their ongoing investment with the opening of their new UK Office in Swindon.
Friday, June 05, 2015
BioTek Nominated for Department of Defense’s Top Employer Award
BioTek Instruments been nominated for the 2015 Secretary of Defense Employer Support Freedom Award by the Employer Support of the Guard and Reserve (ESGR), a Department of Defense (DoD) office.
Tuesday, March 31, 2015
BioTek Receives 2014 Supplier of the Year Award from Fisher Scientific
BioTek was presented with the award at Thermo Fisher Scientific’s annual meeting in Phoenix.
Wednesday, March 25, 2015
BioTek Receives Two Awards from ESGR
Company has received the Patriot Award and the Above and Beyond Award.
Friday, August 22, 2014
BioTek Receives Extraordinary New Product Line Award from Fisher
Company receives award for Cytation 3 Cell Imaging Multi-Mode Reader.
Tuesday, March 04, 2014
BioTek Announces Establishment of Japanese Office
BioTek Japan will be fully functional by July 1, 2013.
Monday, June 10, 2013
BioTek Responds to Growing AP Market Needs with New Taiwan Office
New office will focus on increasing BioTek's brand presence in Taiwan.
Tuesday, May 14, 2013
BioTek Wins Governor's Award for Outstanding Workplace Safety
BioTek receives the award by Governor Peter Shumlin at the 9th Annual Vermont Workplace Safety Conference.
Thursday, April 18, 2013
BioTek Germany Certified in Accordance with EN ISO 13485
Certification guarantees that all of BioTek’s products and services satisfy the requirements and comply with the currently valid legislation.
Monday, December 17, 2012
BioTek Receives European Patent for Microplate Washer Technology
Ultrasonic Advantage uses unique, integrated ultrasonic cleaning to reduce protein and salt crystal build-up.
Tuesday, June 12, 2012
BioTek Expands Asia Pacific Office
BioTek Instruments, Inc., continues their commitment to the Asia Pacific region with the expansion of their Singapore office.
Thursday, May 10, 2012
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!